JAK2 and acute lymphoblastic leukemia: The majority of ALL-associated JAK2 mutations lie within JAK2 exon 16 (Table 2), where the most frequent mutations are JAK2 p. R683G/S (Mullighan et al., 2009a; Harvey et al., 2010; Pui et al., 2017; Kim et al., 2018).